NEW YORK (Reuters Health) – A Danish study indicates that among patients undergoing percutaneous coronary intervention, the use of zotarolimus-eluting stents (ZESs) rather than sirolimus-eluting stents (SESs) is…
NEW YORK (Reuters Health) – The presence of peripheral neuropathy, and not diabetes per se, increases the risk of surgical site infections after foot and ankle surgery, according…
NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study…
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss,…
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who also have liver cirrhosis associated with hepatitis C virus (HCV) infection fare significantly better when they’re treated…
NEW YORK (Reuters Health) – Weight-based insulin doses up to 0.6 unit/kg are associated with a low risk of hypoglycemia, according to a report in the June 23rd…
NEW YORK (Reuters Health) – Patients with depression or diabetes have an increased risk of MI, but the risk is even higher in patients with both conditions, according…
NEW YORK (Reuters Health) – Retinal videos are just as effective as standard still retinal images for detecting diabetic retinopathy, according to results of a comparative study of…
It’s Day One of the 71st Scientific Sessions of the American Diabetes Association, and more than 13,000 diabetes experts are gathered in San Diego. Check back daily for…